1. The DESCRIPA collaborative study on the early diagnosis of Alzheimer’s disease (2003-2007) DESCRIPA
2. The PharmaCog, short for “Prediction of cognitive properties of new drug candidates for neurodegenerative diseases in early clinical development”, a partnership of 32 academic and industry actors from 7 countries and EUR 20.2 million in funding from the Innovative Medicines Initiative (2010-2014) PharmaCog
Alterniity is an Augmented Reality based early diagnostic technology for older people at risk of dementia, especially Alzheimer’s disease. The scientific team leading this MedTech worked alongside ARTORG Centre for Biomedical Engineering Research of the University of Bern and is armed with 11 years of EU funded clinical trials for the development of this technology.
A great start supported by:
© 2016 XtremeVRI AG . All rights reserved.